Takeda Pharmaceutical Co., Ltd. et al v. TWi Pharmaceuticals, Inc.
Filing
130
ORDER RE CASE MANAGEMENT CONFERENCE. Signed by Judge Lucy H. Koh on 12/11/2014. (lhklc3S, COURT STAFF) (Filed on 12/11/2014)
1
2
3
4
5
UNITED STATES DISTRICT COURT
6
NORTHERN DISTRICT OF CALIFORNIA
7
SAN JOSE DIVISION
8
10
TAKEDA PHARMACEUTICAL CO., LTD.,
TAKEDA PHARMACEUTICALS U.S.A.,
INC., AND TAKEDA
PHARMACEUTICALS AMERICA, INC.,
11
Plaintiffs,
United States District Court
For the Northern District of California
9
12
13
14
v.
TWI PHARMACEUTICALS, INC.,
Defendant.
)
)
)
)
)
)
)
)
)
)
)
)
)
Case No.: 13-CV-02420-LHK
ORDER RE CASE MANAGEMENT
CONFERENCE
15
16
At the case management conference held on December 10, 2014, the Court indicated that it
17
would not allow Takeda to reassert claim 6 of the ’187 Patent. Upon further consideration, the
18
Court changed its mind, as reflected in the Court’s Case Management Order. See ECF No. 129.
19
Should TWi need to amend its invalidity contentions as a result of the Court’s decision, the Court
20
will allow TWi to do so.
21
IT IS SO ORDERED.
22
Dated: December 11, 2014
_________________________________
LUCY H. KOH
United States District Judge
23
24
25
26
27
28
1
Case Nos.: 13-CV-02420-LHK
ORDER RE CASE MANAGEMENT CONFERENCE
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?